DP
RNAM

Diadema Partners’s Avidity Biosciences RNAM Stock Holding History

Diadema Partners’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,000
Closed -$1.94M – 187
2025
Q3 		$1.31M Buy
+30,000
New +$1.21M 0.33% 78

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Diadema Partners's RNAM Position: Q4 2025 in Review

Diadema Partners sold out of Avidity Biosciences (RNAM) in Q4 2025, closing a stake of 30,000 shares — an estimated $1.94M sold.

Diadema Partners first reported a position in RNAM in Q3 2025 and held it in 1 quarter. The position peaked at $1.31M in Q3 2025. 343 funds tracked by Wall St. Rank hold RNAM as of Q4 2025.

  • Diadema Partners reported no remaining Avidity Biosciences position as of Q4 2025 after selling out during the quarter.
  • Diadema Partners sold 30,000 Avidity Biosciences shares in Q4 2025, an estimated $1.94M.
  • Diadema Partners first reported a position in Avidity Biosciences in Q3 2025 and held it in 1 quarter.
  • Diadema Partners's Avidity Biosciences position peaked at $1.31M in Q3 2025.
  • 343 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2025.

Based on Diadema Partners's 13F filing for Q4 2025, filed 17 Feb 2026.